Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Mar 31, 2008 by Edgar Snyder

Possible Link Between Singulair and Suicide

Singulair suicide risk

The popular asthma and hay fever drug Singulair may be linked to serious adverse side effects in patients. The U.S. Food and Drug Administration (FDA) is investigating anecdotal reports of suicidal behavior and suicide in users of the medication.

In the past year, manufacturer Merck has added suicidal thinking and behavior, tremors, depression, and anxiety to the list of the Singulair's possible adverse side effects. The FDA has now asked Merck to further investigate Singulair study data about reports of behavior and mood changes, suicidal thoughts, and suicide in patients who took the medication.

The consultation may last up to nine months, and for now doctors are urged to closely monitor patients taking Singulair. Singulair belongs to a class of drugs called leukotriene receptor antagonists. The FDA says that it will investigate whether similar medications, such as Accolate, Zyflo, and Zyflo CR, have negative effects on behavior and mood.

Please note: All of our lawyers are licensed to practice in the state of Pennsylvania. We also have lawyers licensed to practice in Maryland, Ohio, Virginia, and West Virginia, and we associate with experienced attorneys in other states. In addition, all drug-related litigation may involve co-counsel.

Source: "FDA looks into Singulair, risks of suicidal thoughts." USA Today. March 27, 2008.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 30, 2016
September Mocktail: Apple Pie Punch
Sep 28, 2016
Pittsburgh Police Beefing Up DUI Patrols in 2017
Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers